These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1286755)

  • 21. [Problems raising from the control of biological products employed in medicine. Control of sera, vaccines, and biological products in France].
    Desbordes J
    Ann Ist Super Sanita; 1969; 5(3-4):218-81. PubMed ID: 16089166
    [No Abstract]   [Full Text] [Related]  

  • 22. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants].
    Koprowski H
    Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Availability of quality fixed-dose combinations for the treatment of tuberculosis: what can we learn from studying the World Health Organization's vaccine model?
    Blomberg B; Kitler ME; Milstien J; Dellepiane N; Fanning A; Norval PY; Spinaci S
    Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S371-80; discussion S381-7. PubMed ID: 10593721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WHO Expert Committee on Biological Standardization.
    World Health Organ Tech Rep Ser; 2002; 910():1-104, back cover. PubMed ID: 15497598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulatory requirements for vaccine authorisation.
    Jones PG; Cowan G; Gravendyck M; Nagata T; Robinson S; Waits M
    Rev Sci Tech; 2007 Aug; 26(2):379-93. PubMed ID: 17892159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potency assays for therapeutic live whole cell cancer vaccines.
    Petricciani J; Egan W; Vicari G; Furesz J; Schild G
    Biologicals; 2007 Apr; 35(2):107-13. PubMed ID: 16882459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current malaria situation in the Republic of Kazakhstan].
    Bismil'din FB; Shapieva ZhZh; Anpilova EN
    Med Parazitol (Mosk); 2001; (1):24-33. PubMed ID: 11548308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the relevance of the target animal safety test for the quality control of veterinary immunological medicinal products.
    Pöbetanecker A; Cubetaler K
    ALTEX; 1998; 15(5):71-75. PubMed ID: 11178548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consideration of alternative licensing procedures for vaccines for minor species and minor indications--manufacturers' point of view.
    de Foucauld J
    Dev Biol (Basel); 2004; 117():117-21. PubMed ID: 15597627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potency testing of veterinary vaccines: the way from in vivo to in vitro.
    Romberg J; Lang S; Balks E; Kamphuis E; Duchow K; Loos D; Rau H; Motitschke A; Jungbäck C
    Biologicals; 2012 Jan; 40(1):100-6. PubMed ID: 22075457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of a new combined vaccine in pediatric practices.
    Freed GL; Cowan AE; Clark SJ; Santoli J; Bradley J
    Pediatrics; 2006 Aug; 118(2):e251-7. PubMed ID: 16831895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current concepts and future approaches to the development of autologous/autogenous vaccines for veterinary use.
    Tollis M
    Dev Biol (Basel); 2004; 117():55-60. PubMed ID: 15597617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WHO Expert Committee on Biological Standardization.
    World Health Organ Tech Rep Ser; 2002; 904():i-vi, 1-107. PubMed ID: 11980231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Regulation of animal experimentation].
    Glomot R; Deltour G
    Therapie; 1990; 45(4):337-40. PubMed ID: 2399518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and approval of vaccines in the United States.
    Botstein P
    Isr J Med Sci; 1986; 22(3-4):268-71. PubMed ID: 3528047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of bioassays for the characterisation and control of biological therapeutic products produced by biotechnology.
    Thorpe R; Wadhwa M; Mire-Sluis A
    Dev Biol Stand; 1997; 91():79-88. PubMed ID: 9413686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.